article thumbnail

Tobacco Issues Awaiting Robert Califf at the FDA

Bill of Health

Food and Drug Administration (FDA), bringing a drawn out and contentious process to a close. Califf will be the second-ever FDA Commissioner to serve non-consecutive terms, and the first to have been confirmed by the Senate on two separate occasions. Banning Menthol Cigarettes.

FDA 274
article thumbnail

How Can Health IT Help Reform the CDC?

Healthcare IT Today

COVID-19 forced a spike in policy-makers’ interest and willingness to invest in public health; a spike that is unfortunately retreating to the old business as usual. I consulted several experts in health IT to ask how such IT could improve data collection and sharing in public health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Documentation: How PDFs Can Help Providers Expedite Care

HIT Consultant

The transition toward more digital recordkeeping in healthcare began in earnest in 2009 with the passage of the American Recovery and Reinvestment Act. If this documentation is primarily paper-based, researchers could have a difficult time ensuring each piece of documentation meets FDA standards.

FDA 98
article thumbnail

The Heart Health Continuum at #CES2023 – From Prevention and Monitoring to Healthy Eating and Sleep

Health Populi

. “Despite breathtaking medical advancements since President Harry Truman declared war on heart disease 75 years ago, researchers have observed a disturbing trend that started in 2009: America’s death rate from heart-related conditions is climbing again,” the detailed essay explains.

FDA 104
article thumbnail

Health Provider News

Hall Render

Vincent discord reignites after hospital revokes doctors’ privileges New Mexicans to Know: Army veteran Nancy Parson brings passion for health care to Las Cruces Army veteran Nancy Parson brings passion for health care to Las Cruces Missed deadlines lead to $11.5M

article thumbnail

FDA’s Brief To The Fifth Circuit in the AHM Case Is Worth A Read

Drug & Device Law

A perusal of amicus briefs drew more than a few “they should know what they are talking about here” responses to groups of food and drug law scholars (as opposed to DDL bloggers), former FDA commissioners, former FDA officials, and former DOJ officials, among others. The appellate brief from FDA bears that out well.

FDA 59
article thumbnail

Tear Down the Goalposts – Rutgers Wins

Drug & Device Law

Rather, it “obligate[d] only the Secretary of Health and Human Services” to create “‘conditions designed to ensure’ informed consent.” Since the FDCA didn’t “impose any obligations” on anybody but the FDA, “it cannot conflict” with anything these defendants did or didn’t do. 555, 573 (2009), and these antivaxxers didn’t come close.